Home › Astrocytoma › Washington › Seattle
Astrocytoma clinical trials in Seattle, WA
7 studies for Astrocytoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RecruitingPhase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Seattle Children's Hospital, Seattle
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- Swedish Medical Center-First Hill, Seattle
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Seattle Children's Hospital, Seattle
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Fred Hutch Cancer Center, Seattle
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Seattle Children's Hospital, Seattle
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Seattle Children's Hospital, Seattle
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- Chicago, IL9 studies
- New York City, NY9 studies
- Miami, FL7 studies
- Philadelphia, PA7 studies
- Columbus, OH6 studies
- Durham, NC6 studies
- Washington, DC6 studies
- Aurora, CO5 studies
- Cincinnati, OH5 studies
- San Francisco, CA5 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Multiple Myeloma22 studies
- Pancreatic Cancer22 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.